Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-20-137404
Filing Date
2020-12-18
Accepted
2020-12-18 16:03:03
Documents
2
Period of Report
2020-12-14

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2038852-3_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm2038852-3_3seq1.xml 3 5981
2 EXHIBIT 24 tm2038852d3_ex24.htm EX-24 6709
  Complete submission text file 0001104659-20-137404.txt   14139
Mailing Address 250 WEST 55TH STREET NEW YORK NY 10019
Business Address 250 WEST 55TH STREET NEW YORK NY 10019 2127105220
REVIVA PHARMACEUTICALS HOLDINGS, INC. (Issuer) CIK: 0001742927 (see all company filings)

EIN.: 000000000 | State of Incorp.: D8 | Fiscal Year End: 0930
SIC: 2834 Pharmaceutical Preparations

Mailing Address 19925 STEVENS CREEK BLVD., SUITE 100 CUPPERTINO CA 95014
Business Address
Cantillon Marc (Reporting) CIK: 0001818247 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38634 | Film No.: 201400612